BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Zoledronic Acid

An imidobisphosphonate inhibitor of BONE RESORPTION that is used for the treatment of malignancy-related HYPERCALCEMIA; OSTEITIS DEFORMANS; and OSTEOPOROSIS.

299+ PubMed studies analyzed · 48 RCTs · Evidence Score: 55.2

Research Domains

Zoledronic Acid has been studied across 14 research domains including 🦴 Bone & Joint, 🔬 Oncology, 😴 Sleep, 🫘 Kidney, 💊 Pain. The primary research focus is 🦴 Bone & Joint with 64% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Zoledronic Acid, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

bletilla
2 shared targets
pulsatilla
2 shared targets
dimocarpus
2 shared targets
lycopus
2 shared targets
dendrobium
2 shared targets
anemarrhena
2 shared targets
curculigo
2 shared targets
cnidium
2 shared targets
Foeniculum
2 shared targets
gastrodia
2 shared targets
Loading evidence profile...

This evidence profile for Zoledronic Acid is generated deterministically from 299 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.